Authors' reply to Zou et al

Stefano Ciardullo^{1

2}, Marco Carbone^{3

4}, Pietro Invernizzi^{3

4}, Gianluca Perseghin^{1

2}

Affiliations

¹ Department of Medicine and Rehabilitation, Policlinico di Monza, Monza, Italy.
² Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.
³ Division of Gastroenterology, Department of Medicine and Surgery, Center for Autoimmune Liver Diseases, University of Milano-Bicocca, Monza, Italy.
⁴ European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.

Comment

Stefano Ciardullo et al. Liver Int. 2023 Nov.

. 2023 Nov;43(11):2579-2580.

doi: 10.1111/liv.15724. Epub 2023 Sep 7.

Stefano Ciardullo^{1

2}, Marco Carbone^{3

4}, Pietro Invernizzi^{3

4}, Gianluca Perseghin^{1

2}

¹ Department of Medicine and Rehabilitation, Policlinico di Monza, Monza, Italy.
² Department of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.
³ Division of Gastroenterology, Department of Medicine and Surgery, Center for Autoimmune Liver Diseases, University of Milano-Bicocca, Monza, Italy.
⁴ European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.

No abstract available

Comment on

Letter to the editor regarding "Exploring the landscape of steatotic liver disease in the general US population".
Zou H, Xie Y. Zou H, et al. Liver Int. 2023 Nov;43(11):2576-2578. doi: 10.1111/liv.15722. Epub 2023 Sep 4. Liver Int. 2023. PMID: 37665175 No abstract available.

1. Ciardullo S, Carbone M, Invernizzi P, Perseghin G. Exploring the landscape of steatotic liver disease in the general US population. Liver Int. 2023.
1. Rinella ME, Lazarus JV, Ratziu V, et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;40:47-51.
1. Ciardullo S, Perseghin G. Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population. Liver Int. 2021;41(6):1290-1293.
1. Ciardullo S, Perseghin G. Trends in prevalence of probable fibrotic non-alcoholic steatohepatitis in the United States, 1999-2016. Liver Int. 2023;43(2):340-344.
1. Raza SA, Sokale IO, Thrift AP. Burden of high-risk phenotype of heavy alcohol consumption among obese US population: results from National Health and Nutrition Examination survey, 1999-2020. Lancet Reg Health Am. 2023;23:100525.